首页> 外文期刊>Nucleic Acids Research >NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program.
【24h】

NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program.

机译:NF-κB控制内皮细胞的整体促炎反应:促动脉粥样硬化程序的调节证据。

获取原文
获取原文并翻译 | 示例
           

摘要

Activation of the transcription factor NF-kappaB is critical for the tumor necrosis factor-alpha (TNF-alpha)-induced inflammatory response. Here we report the complete gene expression profile from activated microvascular endothelial cells emphasizing the direct contribution of the NF-kappaB pathway. Human microvascular endothelial cell line-1 (HMEC-1) cells were modified to express dominant interfering mutants of the IKK/NF-kappaB signaling module and expression profiles were determined. Our results provide compelling evidence for the virtually absolute dependence of TNF-alpha-regulated genes on NF-kappaB. A constitutively active IKK2 was sufficient for maximal induction of most target genes, whereas a transdominant IkappaBalpha suppressed gene expression. Several genes with a critical role in atherogenesis were identified. The endothelial lipase (EL) gene, a key enzyme involved in lipoprotein metabolism, was investigated more in detail. Binding sites interacting with NF-kappaB in vitro and in vivo were identified and co-transfection experiments demonstrated the direct regulation of the EL promoter by NF-kappaB. We conclude that targeting the IKK/NF-kappaB pathway or specific genes downstream may be effective for the control or prevention of chronic inflammatory diseases such as atherosclerosis.
机译:转录因子NF-κB的激活对于肿瘤坏死因子-α(TNF-α)诱导的炎症反应至关重要。在这里,我们从激活的微血管内皮细胞报告了完整的基因表达谱,强调了NF-κB途径的直接贡献。修改人微血管内皮细胞系1(HMEC-1)细胞,以表达IKK / NF-kappaB信号传导模块的显性干扰突变体,并确定表达谱。我们的结果为TNF-α调控的基因对NF-κB的几乎绝对依赖性提供了有力的证据。具有组成型活性的IKK2足以最大程度地诱导大多数靶基因,而跨基因的IkappaBalpha抑制了基因表达。鉴定了在动脉粥样硬化中起关键作用的几个基因。内皮脂酶(EL)基因,一种参与脂蛋白代谢的关键酶,已被详细研究。鉴定了在体外和体内与NF-κB相互作用的结合位点,并且共转染实验表明NF-κB直接调控EL启动子。我们得出结论,靶向IKK / NF-kappaB途径或下游特定基因可能对控制或预防慢性炎性疾病(如动脉粥样硬化)有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号